MedTrace Logo

A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients

NCT00424619 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-07-16

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine the best dose of Vitamin D to give to hip fracture patients to achieve the optimal therapeutic level.

Conditions

  • Hip Fracture

Interventions

DRUG

Vitamin D2

50 000 IU vitamin D2, one time bolus dose

DRUG

Vitamin D2

100 000 IU vitamin D2, one time bolus dose

DRUG

Placebo

Placebo, 1 time bolus dose

Sponsors & Collaborators

Principal Investigators

  • Alexandra Papaioannou, M.D., M.Sc. · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-07-31
Completion
2009-07-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00424619 on ClinicalTrials.gov